Clinical researech technology provider Clinerion and Semicrol, the creator of Fundanet CTMS, will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s CTMS product.
Clinical researech technology provider Clinerion and Semicrol, the creator of Fundanet CTMS, will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s CTMS product. The partnership will integrate patient data throughout the clinical trial process, from planning to reporting of results, and enable automated sharing of patient data from a hospital’s electronic health records system to the CTMS running a clinical trial at that hospital. The goal is to enable efficient trial processes and patient outcomes that preserve patient data privacy, while patient data remains within the hospital IT infrastructure throughout.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.